BIOMAT Database Logo BIOMAT Database Logo

[Clinical results of retreatment using rifampicin for more than 12 months for pulmonary tuberculosis (author's transl)]. 1973

E Urakami, and S Nagasawa

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

E Urakami, and S Nagasawa
[A long-term observation on previously treated cases of pulmonary tuberculosis retreated with rifampicin for more than six months (author's transl)].
May 1979, Kekkaku : [Tuberculosis],
E Urakami, and S Nagasawa
Trial of rifampicin in the treatment of pulmonary tuberculosis. Results at 12 months.
April 1972, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
E Urakami, and S Nagasawa
[Rifampicin in the retreatment of pulmonary tuberculosis].
June 1973, Harefuah,
E Urakami, and S Nagasawa
Rifampicin--ethambutol in retreatment of pulmonary tuberculosis.
July 1976, The Indian journal of chest diseases & allied sciences,
E Urakami, and S Nagasawa
[Rifampicin treatment for pulmonary tuberculosis--effectiveness of rifampicin on tubercle bacilli in pulmonary lesions (author's transl)].
July 1975, Kekkaku : [Tuberculosis],
E Urakami, and S Nagasawa
[Sputum positive conversion among retreatment cases with pulmonary tuberculosis converted to negative by the use of rifampicin (author's transl)].
January 1979, Kekkaku : [Tuberculosis],
E Urakami, and S Nagasawa
[Clinical study on rifampicin applied every other day for severe cavitary pulmonary tuberculosis (author's transl)].
May 1974, Kekkaku : [Tuberculosis],
E Urakami, and S Nagasawa
Rifampicin and ethambutol in retreatment of chronic pulmonary tuberculosis.
January 1973, Scandinavian journal of respiratory diseases,
E Urakami, and S Nagasawa
[Studies on the therapeutic effects of lividomycin in retreatment for pulmonary tuberculosis (author's transl)].
January 1974, Kekkaku : [Tuberculosis],
E Urakami, and S Nagasawa
Rifampicin in retreatment and original treatment cases of pulmonary tuberculosis.
January 1970, Antibiotica et chemotherapia. Fortschritte. Advances. Progres,
Copied contents to your clipboard!